About a quarter of women experience moderate to severe pain for many years after their treatment ends. In many cases, it's a type of pain that is challenging to treat, with few or no effective options.
The University of Michigan Health System has begun offering a new urine test called Mi-Prostate Score to improve on PSA screening for prostate cancer. The test incorporates three specific markers that could indicate cancer and studies have shown that the combination is far more accurate than PSA alone.
Recent studies have suggested that an informed patient will be less likely to choose a more-extensive treatment than what the doctor recommends but a recent study by University of Michigan Comprehensive Cancer Cetner researchers have found that's not necessarily the case.
University of Michigan Comprehensive Cancer Center researchers Maha Hussain, M.D., and Arul Chinnaiyan, M.D., Ph.D., received two of six grant awards from the Movember-Prostate Cancer Foundation Challenge.
A new study from researchers at the University of Michigan Comprehensive Cancer Center found that these cells, called myeloid derived suppressor cells, provide a niche where the cancer stem cells survive.
Despite taking a tailored risk assessment tool that factors in family history and personal habits, nearly 20 percent of women did not believe their breast cancer risk, according to a new study from the University of Michigan Comprehensive Cancer Center.